Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard H Calabrese

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Arthritis Research & Therapy|October 3, 2008
Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerationsDimitrios Vassilopoulos, Leonard H Calabrese
Current Opinion in Rheumatology|July 18, 2020
Editorial: Reflections on rheumatological aspects of COVID-19Leonard H Calabrese, Cassandra Calabrese
Cleveland Clinic Journal of Medicine|July 11, 2020
Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1Leonard H Calabrese, Cassandra Calabrese
Arthritis and Rheumatism|March 29, 2002
Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapiesDimitrios Vassilopoulos, Leonard H Calabrese
Current Opinion in Rheumatology|October 6, 2007
Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infectionsDimitrios Vassilopoulos, Leonard H Calabrese
Cleveland Clinic Journal of Medicine|April 5, 2012
Q: Should I order an anti-CCP antibody test to diagnose rheumatoid arthritis?Nilanjana Bose, Leonard H Calabrese
Nature Reviews. Rheumatology|August 4, 2009
Therapy: Targeted but not trouble-free: efalizumab and PMLEamonn S Molloy, Leonard H Calabrese
Rheumatic Diseases Clinics of North America|November 29, 2016
Infection and Malignancy in Rheumatic DiseasesKevin L Winthrop, Leonard H Calabrese
Annals of the Rheumatic Diseases|September 7, 2011
Let the fog be lifted: screening for hepatitis B virus before biological therapyKevin L Winthrop, Leonard H Calabrese
Nature Reviews. Rheumatology|August 20, 2014
IL-6 biology: implications for clinical targeting in rheumatic diseaseLeonard H Calabrese, Stefan Rose-John
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Arthritis Research & Therapy|October 3, 2008
Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerationsDimitrios Vassilopoulos, Leonard H Calabrese
Current Opinion in Rheumatology|July 18, 2020
Editorial: Reflections on rheumatological aspects of COVID-19Leonard H Calabrese, Cassandra Calabrese
Cleveland Clinic Journal of Medicine|July 11, 2020
Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1Leonard H Calabrese, Cassandra Calabrese
Arthritis and Rheumatism|March 29, 2002
Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapiesDimitrios Vassilopoulos, Leonard H Calabrese
Current Opinion in Rheumatology|October 6, 2007
Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infectionsDimitrios Vassilopoulos, Leonard H Calabrese
Cleveland Clinic Journal of Medicine|April 5, 2012
Q: Should I order an anti-CCP antibody test to diagnose rheumatoid arthritis?Nilanjana Bose, Leonard H Calabrese
Nature Reviews. Rheumatology|August 4, 2009
Therapy: Targeted but not trouble-free: efalizumab and PMLEamonn S Molloy, Leonard H Calabrese
Rheumatic Diseases Clinics of North America|November 29, 2016
Infection and Malignancy in Rheumatic DiseasesKevin L Winthrop, Leonard H Calabrese
Annals of the Rheumatic Diseases|September 7, 2011
Let the fog be lifted: screening for hepatitis B virus before biological therapyKevin L Winthrop, Leonard H Calabrese
Nature Reviews. Rheumatology|August 20, 2014
IL-6 biology: implications for clinical targeting in rheumatic diseaseLeonard H Calabrese, Stefan Rose-John
Pageof 14